Bell & Brown Wealth Advisors’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $205K | Buy |
77,750
+19,050
| +32% | +$50.3K | 0.07% | 67 |
|
|
2025
Q1 | $177K | Buy |
58,700
+17,300
| +42% | +$52.1K | 0.07% | 68 |
|
|
2024
Q4 | $106K | Buy |
41,400
+4,500
| +12% | +$11.5K | 0.04% | 71 |
|
|
2024
Q3 | $137K | Buy |
36,900
+2,500
| +7% | +$9.3K | 0.05% | 71 |
|
|
2024
Q2 | $217K | Buy |
34,400
+100
| +0.3% | +$632 | 0.08% | 65 |
|
|
2024
Q1 | $184K | Sell |
34,300
-100
| -0.3% | -$537 | 0.08% | 68 |
|
|
2023
Q4 | $173K | Buy |
+34,400
| New | +$173K | 0.08% | 73 |
|
|
2023
Q2 | $55.9K | Buy |
+20,100
| New | +$55.9K | 0.03% | 70 |
|